1. Home
  2. KPTI vs VGI Comparison

KPTI vs VGI Comparison

Compare KPTI & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$5.55

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Logo Virtus Global Multi-Sector Income Fund of Beneficial Interest

VGI

Virtus Global Multi-Sector Income Fund of Beneficial Interest

HOLD

Current Price

$7.38

Market Cap

89.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPTI
VGI
Founded
2008
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.6M
89.0M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
KPTI
VGI
Price
$5.55
$7.38
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$15.33
N/A
AVG Volume (30 Days)
1.0M
44.6K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
12.66%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$46.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$3.51
$7.00
52 Week High
$10.99
$8.09

Technical Indicators

Market Signals
Indicator
KPTI
VGI
Relative Strength Index (RSI) 30.46 31.31
Support Level $3.93 N/A
Resistance Level $6.96 $7.97
Average True Range (ATR) 0.89 0.08
MACD -0.41 -0.02
Stochastic Oscillator 13.61 23.75

Price Performance

Historical Comparison
KPTI
VGI

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest

Virtus Global Multi-Sector Inc is a United States based fund. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objective by applying extensive credit research to capitalize on opportunities across undervalued areas of the international bond markets.

Share on Social Networks: